- Teniposide
drugbox
IUPAC_name =
CAS_number = 29767-20-2
ATC_prefix = L01
ATC_suffix = CB02
PubChem = 34698
DrugBank = APRD00649
C = 32 | H = 32 | O = 13 | S = 1
molecular_weight = 656.655 g/mol
bioavailability = n/a
protein_bound = >99%
metabolism = Hepatic (CYP2C19 -mediated)
elimination_half-life = 5 hours
excretion = Renal and fecal
pregnancy_AU = D
pregnancy_US = D
legal_US = Rx-only
routes_of_administration = IntravenousTeniposide (Vumon, VM-26) is a chemotherapeutic
medication mainly used in the treatment of childhoodacute lymphocytic leukemia . It is in a class of drugs known as podophyllotoxin derivatives and slows the growth ofcancer cells in the body. Common side effects includenausea ,vomiting ,diarrhea , and thinned or brittle hair.The medication is injected though a vein and burns if it leaks under the skin. It is sometimes used in combination with other anticancer drugs.
A major problem with teniposide is the lowered count of
white blood cell s 1–2 weeks after treatment. Though they should return to normal after 3–4 weeks, the decreased count puts a user at a risk ofinfection . The same also occurs forplatelets .
Wikimedia Foundation. 2010.